OB/GYN Clinical Alert – February 1, 2013
February 1, 2013
View Issues
-
Repurposing an Old Drug for Cancer Control: What Does Metformin Bring to the Plate?
in limited clinical trials, metformin has been shown to have anti-cancer activity. The objective of this study was to investigate whether patients taking metformin had better disease-specific survival compared to non-consumers. -
Preventing Unintended Pregnancy
The authors performed a prospective cohort study, the Contraceptive CHOICE Project, in which women at risk of unintended pregnancy in the St. Louis, Missouri, region received a reversible contraceptive method of their choice for up to 3 years at no cost. -
Is Intrauterine Anesthesia Beneficial for Performing Gynecologic Procedures?
The authors performed a search of online databases as well as reference lists from published reviews that evaluated methods of pain control in gynecologic procedures using intrauterine instillations. -
Microarray for Prenatal Diagnosis
It has only been a few months since maternal cell free DNA (cfDNA) testing for trisomies 21, 18, and 13 burst onto the scene to shake up (in a good way) current prenatal testing protocols. -
Are Oral Contraceptives Risky or Protective in Women with Polycystic Ovary Syndrome?
These two groups took slightly different approaches to assess the relationship between polycystic ovary syndrome (PCOS) and venous thromboembolism (VTE) using insurance claims databases. -
Pharmacology Watch: FDA Approves Apixaban for Patients with Nonvalvular AF
The FDA has approved apixaban the long-awaited third novel oral anticoagulant (NOAC) for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF). -
Clinical Briefs in Primary Care supplement